一种新型的阿里纳夫他林类比物准CYP51以抑制Cryptococcus neoformans的生长
Chaowei Zhang1, Meirong Zhao2, Dongyu Huang3
1College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China; School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518000, China.
Bioorganic chemistry
|September 11, 2025
概括
JR20是一种新型原衍生物,通过向CYP51和线粒体,对Cryptococcus neoformans表现出强烈的抗真菌作用. 这种双重作用化合物还在体内证明了治疗疗效和抗炎性质.
科学领域:
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 新型菌 (Cryptococcus neoformans) 构成重大威胁,特别是在免疫力低下的人群中.
- 新兴的抗真菌耐药性需要开发新的治疗药物.
- 利格南衍生物代表了一类具有潜在药用性质的天然产品.
研究的目的:
- 为了研究JR20的抗真菌活性,一种新型的阿里纳乙烯干衍生物.
- 为了阐明JR20对Cryptococcus neoformans的双重作用机制.
- 评估JR20的体内疗效和治疗潜力.
主要方法:
- 分子对接和转录组分析以识别药物点.
- 生物化学试验以评估厄戈斯特醇生物合成和线粒体功能.
- 扫描电子显微镜 (SEM) 和传输电子显微镜 (TEM) 用于细胞形态.
- 流细胞计用于细胞死亡分析.
- 在体内疗效的老鼠深层感染模型.
主要成果:
- JR20对Cryptococcus neoformans (IC50 = 2.82μg/mL) 显示出强大的抗真菌活性.
- 确定了双重机制:与CYP51的特定结合,抑制埃尔戈斯特醇生物合成和破坏真菌膜.
- 诱导了线粒体功能障碍,由膜潜能损失,ROS积累和ATP合成受损证明.
- 在小鼠感染模型中,JR20表现出抗感染和抗炎作用.
结论:
- JR20是一种有前途的抗真菌药物,具有独特的双重作用机制.
- 它克服抗药性途径的能力使其在治疗耐药性真菌感染方面具有价值.
- 自然产品研究为开发新型抗真菌疗法提供了可行的途径.
更多相关视频
09:18Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
1.4K
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
1.1K
相关概念视频
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...